BIOA vs CTVA · rev $9.0M vs P/E 42, rev $16.91B
BioAge Labs, Inc (BIOA) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
BIOA currently screens at market cap $697.9M. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the BIOA and CTVA stock pages for the full models.
Not investment advice.